With the rapid advancement of technology, it is now possible to examine various molecular components that influence tumor behaviours and serve as potential targets for novel therapies, expanding our ability to go beyond single DNA mutation. The development of innovative clinical trial designs, the collection of clinical and molecular data in real-world database.